It is a pharma private limited company based in Allahabad, Uttar Pradesh, India, established in 2019.
2019 | Allahabad, Uttar Pradesh, India | ActiveSkincross Pharmaceutical Private Limited, a active private limited company, was established on 19 September 2019 in Allahabad, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U85100UP2019PTC121434. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.30 M.
Its leadership includes Pooja Sahu (Director), Akhilesh Kumar (Director). Past directors included Amit Kumar Tripathi, Mohammad Naushad, Shoaiba. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sj408 Mangal Vihar Allahbad Allahabad, Allahabad, Uttar Pradesh, 211012.
U85100UP2019PTC121434
121434
19 September 2019
₹0.30 M
₹0.30 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Skincross Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Sahu | Director | 05 Feb 2025 | Current |
| Akhilesh Kumar | Director | 05 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Feb 2025 | Past |
| Pramod Abcsdd | Director | 05 Apr 2022 | Past |
| Pramod Abcsdd | Director | 05 Apr 2022 | Past |
| Pramod Abcsdd | Director | 05 Feb 2025 | Past |
| Pramod Abcsdd | Director | 02 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skincross Pharmaceutical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Skincross Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Skincross Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Skincross Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skincross Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Skincross Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Skincross Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.
Pooja Sahu was appointed as a Director was appointed as a Director on 05 Feb 2025 & has been associated with this company since 9 months 26 days . was recorded as a recent event.
The activity Akhilesh Kumar was appointed as a Director was appointed as a Director on 05 Feb 2025 & has been associated with this company since 9 months 26 days . was completed.
Progress on Skincross Pharmaceutical Private Limited was registered on 19 Sep 2019 with Roc Kanpur & aged 6 years 2 months as per MCA records. was documented.
The CIN of Skincross Pharmaceutical Private Limited is U85100UP2019PTC121434.
Skincross Pharmaceutical Private Limited is headquartered at Sj408 Mangal Vihar Allahbad Allahabad, Allahabad, Uttar Pradesh, 211012.
Skincross Pharmaceutical Private Limited was incorporated on 19 September 2019.
The current directors of Skincross Pharmaceutical Private Limited are
The primary industry of Skincross Pharmaceutical Private Limited is Pharma.
Skincross Pharmaceutical Private Limited is unlisted.
The authorized capital of Skincross Pharmaceutical Private Limited is ₹0.30 M, and the paid-up capital is ₹0.30 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX